T. Rowe Price Associates, Inc. 13D and 13G filings for Adaptive Biotechnologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-12 2:07 pm Sale | 2022-08-31 | 13G | Adaptive Biotechnologies Corporation ADPT | T. Rowe Price Associates, Inc. | 4,081,518 2.900% | -10,159,096 (-71.34%) | Filing |
| 2022-02-10 1:16 pm Purchase | 2022-01-31 | 13G | Adaptive Biotechnologies Corporation ADPT | T. Rowe Price Associates, Inc. | 14,240,614 10.000% | 953,901 (+7.18%) | Filing |
| 2022-02-10 1:13 pm Purchase | 2021-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | T. Rowe Price Associates, Inc. | 13,286,713 9.400% | 13,286,713 (New Position) | Filing |